Grace Therapeutics, Inc. (GRCE) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$9.57M | +25.6% |
| 2024 | -$12.85M | +69.7% |
| 2023 | -$42.43M | -332.1% |
| 2022 | -$9.82M | +50.1% |
| 2021 | -$19.68M | +22.9% |
| 2020 | -$25.51M | +35.2% |
| 2019 | -$39.37M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$9.57M | +25.6% |
| 2024 | -$12.85M | +69.7% |
| 2023 | -$42.43M | -332.1% |
| 2022 | -$9.82M | +50.1% |
| 2021 | -$19.68M | +22.9% |
| 2020 | -$25.51M | +35.2% |
| 2019 | -$39.37M | — |